LuciTofa 5 MG (Tofacitinib)

Description

Tofacitinib

Each film-coated tablet contains Tofacitinib citrate 8 mg equivalent to Tofacitinib … 5mg.

INDICATION

LuciTofa is a Janus kinase (JAK) inhibitor. • Rheumatoid Arthritis: LuciTofa is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. • Psoriatic Arthritis: LuciTofa is indicated for the treatment of adult patients with active psoriatic arthritis who have had an inadequate response or intolerance to methotrexate or other disease- modifying antirheumatic drugs (DMARDs).

DOSAGE AND USE

Recommended Dosage: Rheumatoid Arthritis and Psoriatic Arthritis 5 mg twice daily. Recommended dosage in patients with moderate and severe renal impairment or moderate hepatic impairment is LuciTofa 5 mg once daily.

STORAGE

In a dry place and store at 20°C to 25°C.

MANUFACTURED AND MARKETED BY

LUCIUS PHARMACEUTICALS(LAO) CO., LTD. No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos

WARNING

Keep medicine out of reach of Children. Do not administer LuciTofa during Pregnancy and Lactation.